Jiangsu Hengrui Pharmaceuticals (01276) elects Sun Jieping as the employee representative director.

date
22:52 02/03/2026
avatar
GMT Eight
Jiangsu Hengrui Medicine Co., Ltd. (01276) announced that in accordance with the relevant provisions of the Company Law of the People's Republic of China, the Guidelines on Articles of Association for Listed Companies, the Shanghai Stock Exchange's Guidance on Self-Discipline for Listed Companies, etc., the company held a staff representative assembly on March 2, 2026 to elect Mr. Sun Jieping as the staff representative director of the 10th Board of Directors of the company. His term of office is consistent with that of the 10th Board of Directors of the company.
Jiangsu Hengrui Pharmaceuticals (01276) has announced that, in accordance with the relevant provisions of the Company Law of the People's Republic of China, the Articles of Association of listed companies, and the Shanghai Stock Exchange's Regulatory Guidelines for Listed Companies No. 1 - Standard Operations, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (hereinafter referred to as "the Company") held a Workers' Representative Assembly on March 2, 2026, and elected Mr. Sun Jieping as the Workers' Representative Director of the Tenth Board of Directors of the Company. His term of office is consistent with the term of office of the Tenth Board of Directors of the Company.